SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001193125-17-234866
Filing Date
2017-07-25
Accepted
2017-07-25 14:55:04
Documents
4
Period of Report
2017-05-09
Items
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A d428368d8ka.htm 8-K/A 24122
2 EX-23.1 d428368dex231.htm EX-23.1 2397
3 EX-99.1 d428368dex991.htm EX-99.1 126434
4 EX-99.2 d428368dex992.htm EX-99.2 127684
  Complete submission text file 0001193125-17-234866.txt   281813
Mailing Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612
Business Address 19900 MACARTHUR BLVD. SUITE 550 IRVINE CA 92612 949-238-8090
Novus Therapeutics, Inc. (Filer) CIK: 0001404281 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 001-36620 | Film No.: 17980301
SIC: 2834 Pharmaceutical Preparations